UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 223

Sortiert nach

Blood pressure variability and cardiovascular risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)

PloS one, 2012-12, Vol.7 (12), p.e52438-e52438

2012

Volltextzugriff (PDF)

Long-term impact on healthcare resource utilization of statin treatment, and its cost effectiveness in the primary prevention of cardiovascular disease: a record linkage study

European heart journal, 2014-02, Vol.35 (5), p.290-298

2014

Volltextzugriff (PDF)

Long-term effects of statin treatment in elderly people: extended follow-up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)

PloS one, 2013-09, Vol.8 (9), p.e72642

2013

Volltextzugriff (PDF)

Pravastatin and the development of diabetes mellitus : Evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study

Circulation (New York, N.Y.), 2001-01, Vol.103 (3), p.357-362

2001

Volltextzugriff (PDF)

Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials

Journal of the American College of Cardiology, 2008-01, Vol.51 (4), p.435-443

2008

Volltextzugriff (PDF)

Association of the Trp719Arg Polymorphism in Kinesin-Like Protein 6 With Myocardial Infarction and Coronary Heart Disease in 2 Prospective Trials

Journal of the American College of Cardiology, 2008-01, Vol.51 (4), p.435-443

2008

Volltextzugriff (PDF)

Apolipoprotein E genotype and the cardiovascular disease risk phenotype: Impact of sex and adiposity (the FINGEN study)

Atherosclerosis, 2012-04, Vol.221 (2), p.467-470

2012

Volltextzugriff (PDF)

Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

The New England journal of medicine, 1995-11, Vol.333 (20), p.1301-1308

1995

Volltextzugriff (PDF)

Genome-wide study of gene variants associated with differential cardiovascular event reduction by pravastatin therapy

PloS one, 2012-05, Vol.7 (5), p.e38240-e38240

2012

Volltextzugriff (PDF)

Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study

Thrombosis and haemostasis, 2000-10, Vol.84 (4), p.553

2000

Volltextzugriff (PDF)

Insight into the nature of the CRP–coronary event association using Mendelian randomization

International journal of epidemiology, 2006-08, Vol.35 (4), p.922-931

2006

Volltextzugriff (PDF)

ABCA1 gene variation and heart disease risk reduction in the elderly during pravastatin treatment

Atherosclerosis, 2014-07, Vol.235 (1), p.176-181

2014

Volltextzugriff (PDF)

Genetic variation at the SLCO1B1 gene locus and low density lipoprotein cholesterol lowering response to pravastatin in the elderly

Atherosclerosis, 2012-02, Vol.220 (2), p.413-417

2012

Volltextzugriff (PDF)

Genetic variation at the NPC1L1 gene locus, plasma lipoproteins, and heart disease risk in the elderly[S]

Journal of lipid research, 2010-05, Vol.51 (5), p.1201-1207

2010

Volltextzugriff (PDF)

Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease

Arteriosclerosis, thrombosis, and vascular biology, 2004-08, Vol.24 (8), p.1529

2004

Volltextzugriff (PDF)

KIF6 , LPA , TAS2R50 , and VAMP8 genetic variation, low density lipoprotein cholesterol lowering response to pravastatin, and heart disease risk reduction in the elderly

Atherosclerosis, 2012-02, Vol.220 (2), p.456-462

2012

Volltextzugriff (PDF)

Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in PROSPER

Atherosclerosis, 2008-09, Vol.200 (1), p.109-114

2008

Volltextzugriff (PDF)

The effect of omega-3 fatty acids on the atherogenic lipoprotein phenotype in patients with nephrotic range proteinuria

Clinical nephrology, 2012-06, Vol.77 (6), p.445

2012

Volltextzugriff (PDF)

Activation of hemostasis and decline in cognitive function in older people

Arteriosclerosis, thrombosis, and vascular biology, 2010-03, Vol.30 (3), p.605

2010

Volltextzugriff (PDF)

Omega-3 fatty acids improve postprandial lipaemia in patients with nephrotic range proteinuria

Atherosclerosis, 2009-07, Vol.205 (1), p.296-301

2009

Volltextzugriff (PDF)

Genetic variants in the KIF6 region and coronary event reduction from statin therapy

Human genetics, 2011-01, Vol.129 (1), p.17-23

2011

Volltextzugriff (PDF)

Association between ADAMTS1 matrix metalloproteinase gene variation, coronary heart disease, and benefit of statin therapy

Arteriosclerosis, thrombosis, and vascular biology, 2008-03, Vol.28 (3), p.562

2008

Volltextzugriff (PDF)

The microsomal triglyceride transfer protein gene-493T variant lowers cholesterol but increases the risk of Coronary heart disease

Circulation (New York, N.Y.), 2004-05, Vol.109 (19), p.2279-2284

2004

Volltextzugriff (PDF)

Metabolic basis of hypotriglyceridemic effects of insulin in normal men

Arteriosclerosis, thrombosis, and vascular biology, 1997-07, Vol.17 (7), p.1454

1997

Volltextzugriff (PDF)

Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects

Diabetes (New York, N.Y.), 1998-05, Vol.47 (5), p.779

1998

Volltextzugriff (PDF)

1 – 25 von 223

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(191)
Mit Volltextzugriff
(171)

Publikationsform

Sprache

Englisch
(223)
Japanisch
(42)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Blood pressure variability and cardiovascular risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)

Long-term impact on healthcare resource utilization of statin treatment, and its cost effectiveness in the primary prevention of cardiovascular disease: a record linkage study

Long-term effects of statin treatment in elderly people: extended follow-up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)

Pravastatin and the development of diabetes mellitus : Evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study

Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials

Association of the Trp719Arg Polymorphism in Kinesin-Like Protein 6 With Myocardial Infarction and Coronary Heart Disease in 2 Prospective Trials

Apolipoprotein E genotype and the cardiovascular disease risk phenotype: Impact of sex and adiposity (the FINGEN study)

Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

Genome-wide study of gene variants associated with differential cardiovascular event reduction by pravastatin therapy

Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study

Insight into the nature of the CRP–coronary event association using Mendelian randomization

ABCA1 gene variation and heart disease risk reduction in the elderly during pravastatin treatment

Genetic variation at the SLCO1B1 gene locus and low density lipoprotein cholesterol lowering response to pravastatin in the elderly

Genetic variation at the NPC1L1 gene locus, plasma lipoproteins, and heart disease risk in the elderly[S]

Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease

KIF6 , LPA , TAS2R50 , and VAMP8 genetic variation, low density lipoprotein cholesterol lowering response to pravastatin, and heart disease risk reduction in the elderly

Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in PROSPER

The effect of omega-3 fatty acids on the atherogenic lipoprotein phenotype in patients with nephrotic range proteinuria

Activation of hemostasis and decline in cognitive function in older people

Omega-3 fatty acids improve postprandial lipaemia in patients with nephrotic range proteinuria

Genetic variants in the KIF6 region and coronary event reduction from statin therapy

Association between ADAMTS1 matrix metalloproteinase gene variation, coronary heart disease, and benefit of statin therapy

The microsomal triglyceride transfer protein gene-493T variant lowers cholesterol but increases the risk of Coronary heart disease

Metabolic basis of hypotriglyceridemic effects of insulin in normal men

Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects

Suchergebnisse filtern